[AMED] Amedisys Inc


Type of security: Stock

Sector: Health Care

Industry: Medical/Nursing Services

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 43.21 Change: 0.32 (0.75%)
Ext. hours: Change: 0 (0%)

chart AMED

Refresh chart

Strongest Trends Summary For AMED

AMED is in the medium-term up 11% in 3 months. In the long-term up 121% above S&P in 1 year and up 199% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Amedisys, Inc., together with its subsidiaries, provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The Home Health segment offers a range of services in the homes of individuals who may be recovering from an illness, injury, or surgery. This segment provides skilled nurses, nurse practitioners, home health aides, physical and occupational therapists, speech therapists, and medical social services; and chronic care clinical programs for patients with chronic diseases, such as cardiovascular, respiratory, diabetes, behavioral health, rehabilitative, and medical surgical conditions. The Hospice segment offers care that is designed to provide comfort and support for those who are facing a terminal illness, including heart disease, pulmonary disease, dementia, Alzheimer?s, HIV/AIDS, or cancer. As of December 31, 2013, it owned and operated 367 Medicare-certified home health care centers, 97 Medicare-certified hospice care centers, and 1 hospice inpatient unit

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-20.05 M Cash From Investing Activities-11.82 M Cash From Operating Activities57.04 M Gross Profit138.45 M
Net Profit10.64 M Operating Profit15.53 M Total Assets645.43 M Total Current Assets168.37 M
Total Current Liabilities176.03 M Total Debt95.52 M Total Liabilities266.09 M Total Revenue314.15 M
Technical Data
High 52 week140.23 Low 52 week55.03 Last close126.89 Last change-1.51%
RSI36 Average true range4.48 Beta0.82 Volume144.91 K
Simple moving average 20 days-4.02% Simple moving average 50 days1.67% Simple moving average 200 days15.2%
Performance Data
Performance Week-6.85% Performance Month-0.74% Performance Quart8.6% Performance Half4.14%
Performance Year122.54% Performance Year-to-date8.35% Volatility daily1.97% Volatility weekly4.41%
Volatility monthly9.05% Volatility yearly31.34% Relative Volume270.73% Average Volume497.76 K
New High New Low


2019-03-19 09:48:46 | See what the IHS Markit Score report has to say about Amedisys Inc.

2019-03-17 10:05:02 | Did You Miss Amedisys’s NASDAQ:AMED Whopping 723% Share Price Gain?

2019-03-12 08:47:12 | Here's Why You Should Add Amedisys AMED to Your Portfolio

2019-03-12 07:17:11 | Zacks.com featured expert Kevin Matras highlights: Robert Half International, Caseys General Stores, Amedisys, Foot Locker and Comfort Systems USA

2019-03-11 08:43:12 | Believe in DuPont Analysis? Tap These 5 Top-Ranked Stocks

2019-03-08 09:29:02 | These 5 Low Leverage Stocks Are Safe Bets

2019-03-05 07:30:00 | Amedisys to Present at 29th Annual Oppenheimer Healthcare Conference

2019-02-28 23:46:45 | Amedisys AMED Q4 2018 Earnings Conference Call Transcript

2019-02-28 21:48:16 | Amedisys Inc AMED Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-02-28 18:07:30 | Edited Transcript of AMED earnings conference call or presentation 28-Feb-19 3:00pm GMT

2019-02-28 09:36:00 | Amedisys, Inc. NASDAQ:AMED Is Employing Capital Very Effectively

2019-02-28 07:52:12 | Amedisys AMED Tops Earnings and Revenue Estimates in Q4

2019-02-27 17:00:00 | Amedisys Reports Fourth Quarter and Year End 2018 Financial Results Issues 2019 Guidance

2019-02-25 16:30:00 | Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program

2019-02-25 10:14:03 | Zacks.com featured expert Kevin Matras highlights: Robert Half International, Caseys General Stores, Amedisys, Foot Locker and Comfort Systems USA

2019-02-22 10:44:03 | Quest Diagnostics Grows on Innovation Amid Reimbursement Woe

2019-02-22 09:12:02 | Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean

2019-02-22 07:51:12 | Have Faith in DuPont Analysis & Pick 5 Quality Stocks

2019-02-22 06:37:11 | Should You Invest in the Invesco S&P SmallCap Health Care ETF PSCH?

2019-02-21 09:07:02 | Worried About Rate Hikes? Buy These 5 Low Leverage Stocks

2019-02-21 08:00:00 | Investor Expectations to Drive Momentum within International Business Machines, Trex, ForeScout Technologies, Red Hat, Amedisys, and Atrion — Discovering Underlying Factors of Influence

2019-02-20 14:17:46 | The Fastest-Growing Health Care Stocks All Have This In Common

2019-02-20 10:31:03 | Amedisys AMED Earnings Expected to Grow: Should You Buy?

2019-02-20 08:54:01 | Will Hospice Strength Show on Amedisys' AMED Q4 Earnings?

2019-02-19 16:30:00 | Amedisys Signs Definitive Agreement to Acquire RoseRock Healthcare

2019-02-19 09:32:02 | Medtronic Posts Prelim PRODIGY Outcome on Opioid Overdose

2019-02-19 07:53:12 | Align Technology Unveils iTero Element 5D Imaging System

2019-02-19 07:30:00 | Amedisys Announces Retirement of Board Member Linda J. Hall

2019-02-15 13:13:25 | Cannabis REIT Innovative Industrial Properties Joins Small-Cap Index

2019-02-15 09:33:02 | Here's Why You Must Buy Cardiovascular Systems' CSII Stock

2019-02-14 17:48:00 | Amedisys Set to Join S&P MidCap 400; Innovative Industrial Properties to Join S&P SmallCap 600

2019-02-13 12:16:15 | Media Statement from Amedisys Commending the Home Health Payment Innovation Act

2019-02-13 08:25:01 | Boston Scientific Benefits From New Buyouts & Product Launch

2019-02-13 08:13:01 | Edwards Lifesciences to Buy CASMED to Boost Critical Care Arm

2019-02-13 07:24:12 | Should You Invest in the Invesco DWA Healthcare Momentum ETF PTH?

2019-02-12 08:39:01 | Here's Why You Should Buy IDEXX Laboratories IDXX Stock

2019-02-08 08:05:22 | See what the IHS Markit Score report has to say about Amedisys Inc.

2019-02-07 10:50:03 | Amedisys AMED Upgraded to Buy: What Does It Mean for the Stock?

2019-02-06 14:40:22 | Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date

2019-02-06 04:10:09 | 3 Investment Tips to Help You Achieve Your 2019 Goals

2019-02-05 09:53:54 | What Does Amedisys, Inc.’s NASDAQ:AMED P/E Ratio Tell You?

2019-02-04 07:45:00 | Amedisys Closes on Acquisition of Compassionate Care Hospice

2019-01-30 17:50:10 | Amedisys AMED Gains But Lags Market: What You Should Know

2019-01-30 09:58:02 | Illumina ILMN Q4 Earnings Lag Estimates, Revenues Top Mark

2019-01-30 09:30:02 | ADUS vs. AMED: Which Stock Should Value Investors Buy Now?

2019-01-30 09:30:02 | Is Amedisys AMED Stock Outpacing Its Medical Peers This Year?

2019-01-30 06:38:11 | Should You Invest in the Invesco S&P SmallCap Health Care ETF PSCH?

2019-01-29 09:54:02 | Here's Why You Should Snap Up Abbott ABT Stock Right Now

2019-01-29 09:54:02 | Thermo Fisher TMO Down on Business Divestment Declaration

2019-01-29 08:02:06 | See what the IHS Markit Score report has to say about Amedisys Inc.